A Randomized, Active-Controlled, Double-Blind, Parallel-Goup Study of the Efficacy and Safety of Extended Release(ER) Paliparidone in the Treatment of Schizophrenia
This study has been completed.
Study NCT00350467
Information provided by Xian-Janssen Pharmaceutical Ltd.
First Received: July 7, 2006
Last Updated: September 19, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
